Stoke Therapeutics, Inc
3 clinical trials · Sponsor
◉ Watch Stoke Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome (NCT06872125) | Stoke Therapeutics, Inc | 2025-06-04 |
| An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome (NCT04740476) | Stoke Therapeutics, Inc | 2021-01-20 |
| An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome (NCT04442295) | Stoke Therapeutics, Inc | 2020-06-29 |
Track Stoke Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.